The New York State Gaming Commission (NYSGC) voted Monday to amend its rules for the use of clenbuterol in New York State to follow the model proposed by the Racing Medication and Testing Consortium (RMTC). These rules will go into effect state-wide, including at all three New York Racing Association, Inc. (NYRA) tracks – Belmont Park, Saratoga Race Course and Aqueduct Racetrack – as of June 2.
The full text of the rules for the NYSGC's amendment for the use of clenbuterol in thoroughbred racing [Rule 4043.12(b)(6)] can be found at https://www.gaming.ny.gov/proposedrules.php.
As a reminder, as of January 1, the use of Furosemide (Lasix) is prohibited within 48 hours of all stakes races conducted at NYRA tracks, including the Belmont Stakes.
In April of 2019, NYRA led the formation of a coalition of leading racing organizations founded to address race day medication in a uniform and consistent way throughout the sport. The initiative commenced on January 1, 2020, with NYRA prohibiting Lasix in all 2-year-old races at the three NYRA tracks.
Live racing at the 48-day Belmont Park spring/summer meet continues Thursday with a nine-race card. First post is 3:05 p.m. Eastern.
The post New York: Newly-Amended Clenbuterol Rule Goes Into Effect June 2 appeared first on Horse Racing News | Paulick Report.
